Literature DB >> 32552139

COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.

Valeria M Pinto1, Giorgio E Derchi2, Lorenzo Bacigalupo3, Emanuele Pontali4, Gian Luca Forni1.   

Abstract

We here report the successful recovery from coronavirus disease-19 (COVID-19) pneumonia in a patient with β-thalassemia major (β-TM) and severe pulmonary arterial hypertension (PAH), focusing on the patient's comorbidities, therapeutic course and drug interaction.

Entities:  

Keywords:  Angiotensin II receptor blockers (ARBs); Sildenafil; coronavirus disease-19 (COVID-19); pulmonary arterial hypertension (PAH); thalassemic syndromes

Mesh：

Substances：

Year:  2020        PMID： 32552139     DOI： 10.1080/03630269.2020.1779082

Source DB:  PubMed          Journal:  Hemoglobin        ISSN： 0363-0269            Impact factor:   0.849


  3 in total

Review 1.  Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.

Authors:  Altijana Hromić-Jahjefendić; Debmalya Barh; Cecília Horta Ramalho Pinto; Lucas Gabriel Rodrigues Gomes; Jéssica Lígia Picanço Machado; Oladapo Olawale Afolabi; Sandeep Tiwari; Alaa A A Aljabali; Murtaza M Tambuwala; Ángel Serrano-Aroca; Elrashdy M Redwan; Vladimir N Uversky; Kenneth Lundstrom
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

Review 2.  Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.

Authors:  Harry Karmouty-Quintana; Rajarajan A Thandavarayan; Steven P Keller; Sandeep Sahay; Lavannya M Pandit; Bindu Akkanti
Journal:  Int J Mol Sci       Date:  2020-10-29       Impact factor: 5.923

Review 3.  Hemoglobinopathy and pediatrics in the time of COVID-19.

Authors:  Thiago de Souza Vilela; Josefina Aparecida Pellegrini Braga; Sandra Regina Loggetto
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.